Singapore /mynewsdesk/ — Novus Scientific today announced that the successful adoption of long-term absorbable surgical meshes in the market for soft tissue repair devices has been acknowledged in a new report issued by Millennium Research Group, Inc. The report, “U.S. Markets for Soft Tissue Repair 2012” highlights that synthetic absorbable meshes are beginning to compete for sales within the market by offering the benefits of both biologic products and non-absorbable synthetic meshes.
TIGR® Matrix by Novus Scientific is the archetypal long-term absorbable mesh and is used in soft tissue reinforcement applications by both plastic and general surgeons in a growing list of countries, worldwide.
“We have set out to reshape the landscape of soft tissue surgery and to provide plastic and general surgeons with a new, unique tool that will help them produce better patient outcomes.” said Thomas Engström, founder and CEO of Novus Scientific. “It is encouraging to see how well customers, patients and now also analysts have reacted to us introducing new technology to a standstill market. But we are far from finished yet, improving patient care is our ongoing mission.”
TIGR® Matrix Surgical Mesh is the World’s 1st Long-Term Resorbable, (100% Absorbable) Synthetic Mesh indicated for reinforcement of soft tissue where weakness exists. Its unique patented dual-fiber construction is designed for gradually increasing mechanical compliance, making it strong for 6 months and gone in 3 years. The US Food and Drug Administration (FDA) gave the company 510(k) clearance to market TIGR® Matrix Surgical Mesh in February 2010. In August 2011 Novus Scientific received CE Mark approval from BSI for TIGR® Matrix Surgical Mesh in Europe.
TIGR® Matrix Surgical Mesh is available for sale in the U.S. and selected countries in Europe and Asia.
The report “US Markets for Soft Tissue Repair 2012” is available from Millennium Research Group Inc.
About Novus Scientific
Novus Scientific (www.novusscientific.com) is an innovator in the development and commercialization of absorbable synthetic medical devices. For comprehensive information vist our PRESSROOM:
http://www.mynewsdesk.com/pressroom/novus-scientific
TIGR® is a trademark of Novus Scientific Pte. Ltd
CONTACT:
Henrik Hjort: +46 (0)70 600 97 70
henrik.hjort@novusscientific.com
